ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “AVL”) ISIN Code: ZAE000189049 JSE Code: AVL STRATEGIC REVIEW OF ADVANCED HEALTH Shareholders are referred to the announcement released by AVL on 15 June 2022 and are advised that the strategic review of the Advanced Health group is ongoing. AVL confirms that it has received inbound approaches from several parties interested in a potential acquisition of its shares within PresMed Australia, the Australian subsidiary of AVL. The appointed AVL sub-committee is now further evaluating these approaches, with the assistance of its Australian advisors, Monash Advisory. There are no assurances that the AVL board will decide to pursue, nor that any transaction or transactions will materialise. Shareholders do not need to take any action in relation to this. AVL will continue to keep shareholders informed about the progress and outcomes of the current evaluation process. Pretoria 25 August 2022 Designated Advisor Grindrod Bank Limited